A Phase 1, Proof-of-concept, randomized, double-blind, placebo-controlled, four-way cross-over study of TRV045 to test the mechanism of action and measure evidence of target engagement

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 18 Oct 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Oct 2023 Results presented in a Trevena Media Release.
06 Sep 2023 According to a Trevena media release, Full Safety and Tolerability Data Expected in early 4Q 2023
06 Sep 2023 Preliminary results presented in a Trevena media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com